A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging

Amino Acids

Volumn 44, Issue 2, 2013, Pages 673-681

  Jiang, Han ^a,b   Moore, Sarah J ^c   Liu, Shuanglong ^b   Liu, Hongguang ^b   Miao, Zheng ^b   Cochran, Frank V ^c   Liu, Yang ^a,b   Tian, Mei ^a   Cochran, Jennifer R ^c   Zhang, Hong ^a   Cheng, Zhen ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

v 3 integrin; 18F; Knottin; PET

Indexed keywords

4 NITROPHENYL 2 FLUOROPROPRIONATE AGOUTI RELATED PROTEIN 7C F 18; 4 NITROPHENYL 2 FLUOROPROPRIONATE AGOUTI RELATED PROTEIN 7C F 19; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; FLUORINATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

AGOUTI-RELATED PROTEIN; ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MICE; MICE, NUDE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS;

AGOUTI; ANIMALIA; MUS;

EID: 84878363106     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1391-y     Document Type: Article

References (26)

1. Backberg M, Madjid N, Ogren SO, Meister B (2004) Down-regulated expression of agouti-related protein (AGRP) mRNA in the hypothalamic arcuate nucleus of hyperphagic and obese tub/tub mice. Brain Res Mol Brain Res 125(1-2):129-139. doi: 10.1016/j.molbrainres.2004.03.012
2. Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nahrig J, Watzlowik P, Wester HJ, Harbeck N, Schwaiger M (2008) Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med 49(2):255-259. doi: 10.2967/jnumed.107.045526
3. Cheng Z, Xiong Z, Subbarayan M, Chen X, Gambhir SS (2007a) 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression. Bioconjug Chem 18(3):765-772. doi: 10.1021/bc060306g
4. Cheng Z, Zhang L, Graves E, Xiong ZM, Dandekar M, Chen XY, Gambhir SS (2007b) Small-animal PET of melanocortin 1 receptor expression using a F-18-labeled alpha-melanocyte-stimulating hormone analog. J Nucl Med 48(6):987-994. doi: 10.2967/jnumed.107.039602
5. Cheng Z, De Jesus OP, Namavari M, De A, Levi J, Webster JM, Zhang R, Lee B, Syud FA, Gambhir SS (2008) Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med 49(5):804-813. doi: 10.2967/jnumed.107.047381
6. Cheng Z, De Jesus OP, Kramer DJ, De A, Webster JM, Gheysens O, Levi J, Namavari M, Wang S, Park JM, Zhang R, Liu H, Lee B, Syud FA, Gambhir SS (2010) 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol 12(3):316-324. doi: 10.1007/s11307-009-0256-6
7. Daly NL, Craik DJ (2011) Bioactive cystine knot proteins. Curr Opin Chem Biol. doi: 10.1016/j.cbpa.2011.02.008
8. Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R, Kessler H, Schwaiger M (2001) Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 61(5):1781-1785
9. Haubner RH, Wester HJ, Weber WA, Schwaiger M (2003) Radiotracer-based strategies to image angiogenesis. Q J Nucl Med 47(3):189-199
10. Haubner R, Kuhnast B, Mang C, Weber WA, Kessler H, Wester HJ, Schwaiger M (2004) [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem 15(1):61-69. doi: 10.1021/bc034170n
11. Hersey P, Sosman J, O'Day S, Richards J, Bedikian A, Gonzalez R, Sharfman W, Weber R, Logan T, Buzoianu M, Hammershaimb L, Kirkwood JM (2010) A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer 116(6):1526-1534. doi: 10.1002/cncr.24821
12. Huang L, Gainkam LO, Caveliers V, Vanhove C, Keyaerts M, De Baetselier P, Bossuyt A, Revets H, Lahoutte T (2008) SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol 10(3):167-175. doi: 10.1007/s11307-008-0133-8
13. Jiang L, Kimura RH, Miao Z, Silverman AP, Ren G, Liu H, Li P, Gambhir SS, Cochran JR, Cheng Z (2010) Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin. J Nucl Med 51(2):251-258. doi: 10.2967/jnumed.109.069831
14. Kimura RH, Cheng Z, Gambhir SS, Cochran JR (2009a) Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res 69(6):2435-2442. doi: 10.1158/0008-5472.CAN-08-2495
15. Kimura RH, Levin AM, Cochran FV, Cochran JR (2009b) Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Proteins 77(2):359-369. doi: 10.1002/Prot.22441
16. Kimura RH, Miao Z, Cheng Z, Gambhir SS, Cochran JR (2010) A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjugate Chem 21(3):436-444. doi: 10.1021/Bc9003102
17. Kimura RH, Jones DS, Jiang L, Miao Z, Cheng Z, Cochran JR (2011) Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein. PLoS One 6(2):e16112. doi: 10.1371/journal.pone.0016112
18. Kolmar H (2010) Engineered cystine-knot miniproteins for diagnostic applications. Expert Rev Mol Diagn 10(3):361-368. doi: 10.1586/erm.10.15
19. Li RH, Hoess RH, Bennett JS, DeGrado WF (2003) Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng 16(1):65-72. doi: 10.1093/proeng/gzg002
20. Liu S, Liu Z, Chen K, Yan Y, Watzlowik P, Wester HJ, Chin FT, Chen X (2010) 18F-labeled galacto and PEGylated RGD dimers for PET imaging of alphavbeta3 integrin expression. Mol Imaging Biol 12(5):530-538. doi: 10.1007/s11307-009-0284-2
21. Miao Z, Ren G, Liu H, Kimura RH, Jiang L, Cochran JR, Gambhir SS, Cheng Z (2009) An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem 20(12):2342-2347. doi: 10.1021/bc900361g
22. Miao Z, Levi J, Cheng Z (2010) Protein scaffold-based molecular probes for cancer molecular imaging. Amino Acids. doi: 10.1007/s00726-010-0503-9
23. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278(5335):135-138
24. Ren G, Zhang R, Liu Z, Webster JM, Miao Z, Gambhir SS, Syud FA, Cheng Z (2009) A 2-helix small protein labeled with 68 Ga for PET imaging of HER2 expression. J Nucl Med 50(9):1492-1499. doi: 10.2967/jnumed.109.064287
25. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL (1997) Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Gene Dev 11(5):593-602
26. Silverman AP, Levin AM, Lahti JL, Cochran JR (2009) Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. J Mol Biol 385(4):1064-1075. doi: 10.1016/j.jmb.2008.11.004